1-15 of 15
Marcus Lind
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Severe COVID-19 Infection in Type 1 and Type 2 Diabetes During the First Three Waves in Sweden

Jon Edqvist, Christina Lundberg, Karin Andreasson, Lena Björck, Pigi Dikaiou, Johnny Ludvigsson, Marcus Lind, Martin Adiels, Annika Rosengren
Journal: Diabetes Care
Diabetes Care 2023;46(3):570–578
DOI: https://doi.org/10.2337/dc22-1760
Published: 06 January 2023
View article titled, Severe COVID-19 Infection in Type 1 and Type 2 Diabetes During the First Three Waves in Sweden
Click here to open pdf in another window PDF for Severe COVID-19 Infection in Type 1 and Type 2 Diabetes During the First Three Waves in Sweden
Journal Articles

Glycemic Control and Risk of Sepsis and Subsequent Mortality in Type 2 Diabetes

Anca Balintescu, Marcus Lind, Mikael Andersson Franko, Anders Oldner, Maria Cronhjort, Ann-Marie Svensson, Björn Eliasson, Johan Mårtensson
Journal: Diabetes Care
Diabetes Care 2022;45(1):127–133
DOI: https://doi.org/10.2337/dc21-1050
Published: 28 December 2021
View article titled, Glycemic Control and Risk of Sepsis and Subsequent Mortality in Type 2 Diabetes
Click here to open pdf in another window PDF for Glycemic Control and Risk of Sepsis and Subsequent Mortality in Type 2 Diabetes
Journal Articles

Historical HbA1c Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88

Marcus Lind, Henrik Imberg, Ruth L. Coleman, Olle Nerman, Rury R. Holman
Journal: Diabetes Care
Diabetes Care 2021;44(10):2231–2237
DOI: https://doi.org/10.2337/dc20-2439
Published: 08 July 2021
View article titled, Historical HbA<sub>1c</sub> Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88
Click here to open pdf in another window PDF for Historical HbA<sub>1c</sub> Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88
Journal Articles

Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial

Johnny Ludvigsson, Zdenek Sumnik, Terezie Pelikanova, Lia Nattero Chavez, Elena Lundberg, Itxaso Rica, Maria A. Martínez-Brocca, Marisol Ruiz de Adana, Jeanette Wahlberg, Anastasia Katsarou, Ragnar Hanas, Cristina Hernandez, Maria Clemente León, Ana Gómez-Gila, Marcus Lind, Marta Ferrer Lozano, Theo Sas, Ulf Samuelsson, Stepanka Pruhova, Fabricia Dietrich, Sara Puente Marin, Anders Nordlund, Ulf Hannelius, Rosaura Casas
Journal: Diabetes Care
Diabetes Care 2021;44(7):1604–1612
DOI: https://doi.org/10.2337/dc21-0318
Published: 21 May 2021
View article titled, Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial
Click here to open pdf in another window PDF for Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial
Journal Articles

Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI

Marcus Lind, Arndís F. Ólafsdóttir, Irl B. Hirsch, Jan Bolinder, Sofia Dahlqvist, Aldina Pivodic, Jarl Hellman, Magnus Wijkman, Erik Schwarcz, Henrik Albrektsson, Tim Heise, William Polonsky
Journal: Diabetes Care
Diabetes Care 2021;44(1):141–149
DOI: https://doi.org/10.2337/dc20-1468
Published: 16 November 2020
View article titled, Sustained Intensive Treatment and Long-term Effects on HbA<sub>1c</sub> Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI
Click here to open pdf in another window PDF for Sustained Intensive Treatment and Long-term Effects on HbA<sub>1c</sub> Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI
Journal Articles

The Association Between HbA1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)

Shilan Seyed Ahmadi, Klara Westman, Aldina Pivodic, Arndís F. Ólafsdóttir, Sofia Dahlqvist, Irl B. Hirsch, Jarl Hellman, Magnus Ekelund, Tim Heise, William Polonsky, Magnus Wijkman, Erik Schwarcz, Marcus Lind
Journal: Diabetes Care
Diabetes Care 2020;43(9):2017–2024
DOI: https://doi.org/10.2337/dc19-2606
Published: 08 July 2020
View article titled, The Association Between HbA<sub>1c</sub> and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)
Click here to open pdf in another window PDF for The Association Between HbA<sub>1c</sub> and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)
Journal Articles

Risk Factors for Atrial Fibrillation in People With Type 1 Diabetes: An Observational Cohort Study of 36,258 Patients From the Swedish National Diabetes Registry

Sara Hallström, Aldina Pivodic, Annika Rosengren, Arndís F. Ólafsdóttir, Ann-Marie Svensson, Marcus Lind
Journal: Diabetes Care
Diabetes Care 2019;42(8):1530–1538
DOI: https://doi.org/10.2337/dc18-2457
Published: 06 June 2019
View article titled, Risk Factors for Atrial Fibrillation in People With Type 1 Diabetes: An Observational Cohort Study of 36,258 Patients From the Swedish National Diabetes Registry
Click here to open pdf in another window PDF for Risk Factors for Atrial Fibrillation in People With Type 1 Diabetes: An Observational Cohort Study of 36,258 Patients From the Swedish National Diabetes Registry
Includes: Supplementary data
Journal Articles

Dapagliflozin Plus Saxagliptin Add-on Therapy Compared With Insulin in Patients With Type 2 Diabetes Poorly Controlled by Metformin With or Without Sulfonylurea Therapy: A Randomized Clinical Trial

Tina Vilsbøll, Ella Ekholm, Eva Johnsson, Nalina Dronamraju, Serge Jabbour, Marcus Lind
Journal: Diabetes Care
Diabetes Care 2019;42(8):1464–1472
DOI: https://doi.org/10.2337/dc18-1988
Published: 04 June 2019
View article titled, Dapagliflozin Plus Saxagliptin Add-on Therapy Compared With Insulin in Patients With Type 2 Diabetes Poorly Controlled by Metformin With or Without Sulfonylurea Therapy: A Randomized Clinical Trial
Click here to open pdf in another window PDF for Dapagliflozin Plus Saxagliptin Add-on Therapy Compared With Insulin in Patients With Type 2 Diabetes Poorly Controlled by Metformin With or Without Sulfonylurea Therapy: A Randomized Clinical Trial
Includes: Supplementary data
Journal Articles

BMI, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes: Findings Against an Obesity Paradox

Jon Edqvist, Araz Rawshani, Martin Adiels, Lena Björck, Marcus Lind, Ann-Marie Svensson, Sofia Gudbjörnsdottir, Naveed Sattar, Annika Rosengren
Journal: Diabetes Care
Diabetes Care 2019;42(7):1297–1304
DOI: https://doi.org/10.2337/dc18-1446
Published: 02 May 2019
View article titled, BMI, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes: Findings Against an Obesity Paradox
Click here to open pdf in another window PDF for BMI, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes: Findings Against an Obesity Paradox
Includes: Supplementary data
Journal Articles

Glucose Variables in Type 1 Diabetes Studies With Dapagliflozin: Pooled Analysis of Continuous Glucose Monitoring Data From DEPICT-1 and -2

Chantal Mathieu, Paresh Dandona, Moshe Phillip, Tal Oron, Marcus Lind, Lars Hansen, Fredrik Thorén, John Xu, Anna Maria Langkilde, on behalf of the DEPICT-1 and DEPICT-2 Investigators
Journal: Diabetes Care
Diabetes Care 2019;42(6):1081–1087
DOI: https://doi.org/10.2337/dc18-1983
Published: 09 April 2019
View article titled, Glucose Variables in Type 1 Diabetes Studies With Dapagliflozin: Pooled Analysis of Continuous Glucose Monitoring Data From DEPICT-1 and -2
Click here to open pdf in another window PDF for Glucose Variables in Type 1 Diabetes Studies With Dapagliflozin: Pooled Analysis of Continuous Glucose Monitoring Data From DEPICT-1 and -2
Includes: Supplementary data
Journal Articles

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

Chantal Mathieu, Paresh Dandona, Pieter Gillard, Peter Senior, Christoph Hasslacher, Eiichi Araki, Marcus Lind, Stephen C. Bain, Serge Jabbour, Niki Arya, Lars Hansen, Fredrik Thorén, Anna Maria Langkilde, DEPICT-2 Investigators, Cecilia Luquez, Federico Perez Manghi, Maria Rosa Ulla, Maria Alejandra Moisello, Virginia Visco, Silvia Gorban De Lapertoza, Silvana Ernestina Solis, Javier Farias, Georgina Sposetti, Pieter Gillard, Pascale Abrams, Marina van Ypersele de Strihou, James Conway, Sue Pedersen, Peter Senior, Joanne F. Liutkus, Churn-Ern Yip, Zubin Punthakee, Frederic Bernier, Heather Lochnan, Vincent Woo, Thomas Elliott, Juan Palma, Carmen Solis Merino, Alfredo Danin Vargas, Ulrich Wendisch, Andreas Reichel, Jochen Seufert, Bernd Becker, Hasan Alawi, Andreas L. Birkenfeld, Christoph Hasslacher, Joerg Luedemann, Thomas Schaum, Cornelia Marck, Joachim Sauter, Ulrich Aigner, Yukiko Onishi, Hiroaki Seino, Yuichi Sato, Kiyohide Nunoi, Akira Yamauchi, Eitaro Nakashima, Hiroki Ikeda, Toshihiko Shiraiwa, Yoshimitsu Yamasaki, Hiroki Yokoyama, Kunihiko Nakamura, Masayuki Noritake, Shozo Miyauchi, Tomomi Hakoda, Yoshihide Hirohata, Atsushi Hasegawa, Yoshihide Fukumoto, Hirotaka Nagashima, Masahiro Takihata, Tetsuro Kamada, Hideaki Jinnouchi, Yuri Ono, Takayuki Watanabe, Hiroshi Ohashi, Masahiko Takai, Tadashi Seguchi, Katsuya Yamazaki, Hajime Maeda, Shingo Iwasaki, H.W. De Valk, Adriaan Kooy, Sabine Landewe-Cleuren, Katarzyna Madziarska, Andrzej Stankiewicz, Katarzyna Wasilewska, Gottfried Rudofsky, Maciej Malecki, Ewa Pankowska, Ewa Szyprowska, Monika Lukaszewicz, Lidia Tokarska, Irina Bondar, Irina Karpova, Ludmila Ruyatkina, Alsu Zalevskaya, Ruslan Sardinov, Yury Khalimov, Folke Sjoberg, Pekka Koskinen, Dan Curiac, Marcus Lind, Birgit Bach-Kliegel, Bernd Schultes, Basil G. Issa, Anne Kilvert, Olivia Pereira, Stephen Bain, Biswa Mishra, Deepak Bhatnagar, Leonard Chuck, David Gorson, David Robertson, Luis Casaubon, Louis Chaykin, Juan Pablo Frias, Stanley Hsia, Robert Jenders, Sam Lerman, Scott Segel, Peter Weissman, Anna Chang, John Reed, Ivy-Joan Madu, Peter Bressler, Lisa Abbott, Sumana Gangi, Kate Wheeler, Kenneth Cohen, William Biggs, Serge Jabbour, Dennis Karounos, Sajeev Menon, Wendell Miers, Grazia Aleppo, Gigi Lefebvre, Danny Sugimoto, Robert Ferraro, Richard Kelly, Marcel Twahirwa, Christopher Case, David Klonoff, Paul Denker, Priscilla Hollander, Michelle Welch, Matthew Leinung, Larry Kotek, Janet McGill, Yshay Shlesinger, Cynthia Huffman, Stephen Aronoff, Daniel Lorber, Antonio Terrelonge, Firas Akhrass, Cindy Bredefeld, Kenneth Hershon, James Lenhard, Daniel Donovan, Larry Stonesifer, Craig Greenberg, Eli Ipp, Anuj Bhargava, Shichun Bao
Journal: Diabetes Care
Diabetes Care 2018;41(9):1938–1946
DOI: https://doi.org/10.2337/dc18-0623
Published: 19 July 2018
View article titled, Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial
Click here to open pdf in another window PDF for Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial
Includes: Supplementary data
Journal Articles

BMI and Mortality in Patients With New-Onset Type 2 Diabetes: A Comparison With Age- and Sex-Matched Control Subjects From the General Population

Jon Edqvist, Araz Rawshani, Martin Adiels, Lena Björck, Marcus Lind, Ann-Marie Svensson, Sofia Gudbjörnsdottir, Naveed Sattar, Annika Rosengren
Journal: Diabetes Care
Diabetes Care 2018;41(3):485–493
DOI: https://doi.org/10.2337/dc17-1309
Published: 03 January 2018
View article titled, BMI and Mortality in Patients With New-Onset Type 2 Diabetes: A Comparison With Age- and Sex-Matched Control Subjects From the General Population
Click here to open pdf in another window PDF for BMI and Mortality in Patients With New-Onset Type 2 Diabetes: A Comparison With Age- and Sex-Matched Control Subjects From the General Population
Includes: Supplementary data
Journal Articles

Contemporary Risk Estimates of Three HbA1c Variables for Myocardial Infarction in 101,799 Patients Following Diagnosis of Type 2 Diabetes

Marita Olsson, Volker Schnecke, Claudia Cabrera, Stanko Skrtic, Marcus Lind
Journal: Diabetes Care
Diabetes Care 2015;38(8):1481–1486
DOI: https://doi.org/10.2337/dc14-2351
Published: 26 May 2015
View article titled, Contemporary Risk Estimates of Three HbA<sub>1c</sub> Variables for Myocardial Infarction in 101,799 Patients Following Diagnosis of Type 2 Diabetes
Click here to open pdf in another window PDF for Contemporary Risk Estimates of Three HbA<sub>1c</sub> Variables for Myocardial Infarction in 101,799 Patients Following Diagnosis of Type 2 Diabetes
Includes: Supplementary data
Journal Articles

Relationship Between Overweight and Obesity With Hospitalization for Heart Failure in 20,985 Patients With Type 1 Diabetes: A population-based study from the Swedish National Diabetes Registry

Daniel Vestberg, MD, Annika Rosengren, MD, Marita Olsson, PHD, Soffia Gudbjörnsdottir, MD, Ann-Marie Svensson, RN, Marcus Lind, MD
Journal: Diabetes Care
Diabetes Care 2013;36(9):2857–2861
DOI: https://doi.org/10.2337/dc12-2007
Published: 13 August 2013
View article titled, Relationship Between Overweight and Obesity With Hospitalization for Heart Failure in 20,985 Patients With Type 1 Diabetes: <span class="subtitle">A population-based study from the Swedish National Diabetes Registry</span>
Click here to open pdf in another window PDF for Relationship Between Overweight and Obesity With Hospitalization for Heart Failure in 20,985 Patients With Type 1 Diabetes: <span class="subtitle">A population-based study from the Swedish National Diabetes Registry</span>
Journal Articles

Relationship Between Glycosylated Hemoglobin Assessment and Glucose Therapy Intensification in Patients With Diabetes Hospitalized for Acute Myocardial Infarction

Joshua M. Stolker, MD, John A. Spertus, MD, Darren K. McGuire, MD, Marcus Lind, MD, Fengming Tang, MS, Philip G. Jones, MS, Silvio E. Inzucchi, MD, Saif S. Rathore, PHD, Thomas M. Maddox, MD, Frederick A. Masoudi, MD, Mikhail Kosiborod, MD
Journal: Diabetes Care
Diabetes Care 2012;35(5):991–993
DOI: https://doi.org/10.2337/dc11-1839
Published: 11 April 2012
View article titled, Relationship Between Glycosylated Hemoglobin Assessment and Glucose Therapy Intensification in Patients With Diabetes Hospitalized for Acute Myocardial Infarction
Click here to open pdf in another window PDF for Relationship Between Glycosylated Hemoglobin Assessment and Glucose Therapy Intensification in Patients With Diabetes Hospitalized for Acute Myocardial Infarction